Pharmacogenetic variants and treatment-related toxicity during consolidation therapy in a child with Down syndrome-associated acute lymphoblastic leukemia: a case report
Pharmacogenetic variants and treatment-related toxicity during consolidation therapy in a child with Down syndrome-associated acute lymphoblastic leukemia: a case report. // Pediatric Hematology Oncology Journal. – URL: https://www.sciencedirect.com/science/article/pii/S2468124526000744?dgcid=rss_sd_all
Pharmacogenetic variants and treatment-related toxicity during consolidation therapy in a child with Down syndrome-associated acute lymphoblastic leukemia: a case report. Pediatric Hematology Oncology Journal. https://www.sciencedirect.com/science/article/pii/S2468124526000744?dgcid=rss_sd_all
“Pharmacogenetic variants and treatment-related toxicity during consolidation therapy in a child with Down syndrome-associated acute lymphoblastic leukemia: a case report.” Pediatric Hematology Oncology Journal.
@article{article61560,
title = {Pharmacogenetic variants and treatment-related toxicity during consolidation therapy in a child with Down syndrome-associated acute lymphoblastic leukemia: a case report},
journal = {Pediatric Hematology Oncology Journal},
url = {https://www.sciencedirect.com/science/article/pii/S2468124526000744?dgcid=rss_sd_all}
}
ABSTRACT Aim To investigate the longitudinal association between early‐life movement behaviour patterns and later clinically diagnosed obesity. Method In the population‐based All Babies in Southeast Sweden (ABIS) cohort, 16 415 children...